Home

BioVie Manufactures Novel Terlipressin Prefilled Syringe

Tailwinds' Take: this is exciting news for BioVie. If BIV201 gets approved, one can assume the drug will gain fairly quick and broad acceptance...

Several Thoughts On Micro-Cap Stocks I Follow

The market seems took a little hit this week, then bounced back. The net result of which was the wind coming out of the...

Politics and Asset Prices

The other day a reader was kind enough to send me a video of a terrific interaction between two hedge fund legends.  Last month,...

Bioasis Appoints Consultant Chief Medical Officer and Nominates Medical Oncology Advisory Board

Tailwinds' Take: the science behind XB3™ appears to be very interesting to the medical community. Hopefully this translates into some strategic partnerships soon. GUILFORD, Conn.–(Business...

Curt Medeiros, President of OPTUM Advanced Data and Analytics at UnitedHealth Group, Joins Catasys...

Tailwinds' Take: Medeiros is a great hire for CATS. His resume is impressive and his experience meshes very well with the future envisioned by...

Introducing INmune Bio

We are initiating coverage today on INmune Bio (Nasdaq: INMB). According to the Company, INmune (INMB) is “Reprogramming the Innate Immune System for the...

INmune Bio, Inc. Announces First Alzheimer’s Disease Patient Dosed in XPro1595 Study

Tailwinds' Take: this trial looks poised for success as XPro1595 is known to be safe and reduce inflammation, the endpoints for this trial design.  LA...

INmune Bio Inc. to Discuss Potential New Alzheimer’s Disease Treatments in CTAD Pre-Conference Webinar

LA JOLLA, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- -- INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing treatments that harness the patient’s...

RateGain launches VR Gain to power revenue management and distribution for the Vacation Rentals...

Tailwinds' Take: RateGain (DHISCO) is really starting to position for growth and to be the player in the vacation Rental space. See their press...

Anixa Biosciences Announces Genesis Research to Join Cchek™ Prostate Cancer Study

Tailwinds' Take: there is some momentum building behind Cchek as partners are signing on rapidly. Once it's approved, groups like this will turn into...

Deep Fried Turkey

Those who know me well are well aware that Wednesdays are my favorite night of the week. That's the night I go out mountain...

Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek™ Prostate Cancer Study

SAN JOSE, Calif., Nov. 22, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the...

European Commission Votes in Favor on Nicotinamide Riboside Chloride as a Novel Food

LOS ANGELES, Nov. 20, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today announced that European Member States have voted in favor of listing Nicotinamide...

Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek™ Prostate Cancer Study

Tailwinds' Take: key sentence here is from Dr. Kumar's quote, "commercial launch later this year." SAN JOSE, Calif., Nov. 20, 2019 /PRNewswire/ -- Anixa Biosciences, Inc....

Catasys Appoints Industry Executive Gus Giraldo to Board of Directors

Santa Monica, CA – November 19, 2019 – Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today...

Trade Alert, November 19, 2019

~ Trade alerts discuss changes to Tailwinds' managed portfolios. They are available for premium subscribers only. The information contained here is not meant to...

INmune Bio, Inc. Strengthens Board of Directors with Appointment of Veteran Finance Executive Marcia...

LA JOLLA, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) --  INmune Bio, Inc. (NASDAQ: INMB), an immunology company developing treatments that harness the patient’s innate immune...

Hancock Jaffe Medical Team to Make Presentations at 46th Annual VEITH Vascular Symposium November...

IRVINE, California., November 19, 2019 – Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health,...

WiSA Announces Shipment of Enclave Audio’s WiSA Certified CineHome Speaker Systems, Delivering Immersive, Wireless,...

Tailwinds' Take: a system that brings immersive sound at the cost of a high-end soundbar? Amazing systems like this one from Enclave are why...

Recapping The Recent Earnings Reports

The last couple weeks have seen a slew of earnings reports and, more importantly, investor update calls from companies in the Tailwinds Universe. Importantly...

Become a Tailwinds Member

All our articles are free for everyone to enjoy, however you must register as a user. Please take the time to sign up, it’s free and we do not share your information with anyone.

For those interested in receiving alerts when we buy or sell stocks for our managed accounts, you should consider becoming a premium subscriber. A premium subscription costs $250 per year and subscribers get emails about every transaction taken in our portfolios, including names that have yet to be added to the Tailwinds site.

SIGN ME UP

DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.